Abstracts tagged "polymyalgia rheumatica and positron emission tomography (PET)"

Abstract Number: 2195 • 2018 ACR/ARHP Annual Meeting
Predictive Factors of a Positive PET/CT Scan for Vascular Involvement in Patients with Polymyalgia Rheumatica
Diana Prieto Peña¹, Monica Calderón Goercke¹, Javier Loricera², Isabel Martínez-Rodríguez³, Ignacio Banzo³, Belén Atienza-Mateo⁴, José Luis Martín-Varillas⁴, Vanesa Calvo-Río¹, Carmen Gonzalez Vela⁵, Alfonso Corrales⁴, Santos Castañeda⁶, Ricardo Blanco⁴, José Luis Hernández² and Miguel Angel González-Gay⁷, ¹Rheumatology, Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ²Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ³Nuclear Medicine, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ⁴Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ⁵Pathology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ⁶Rheumatology, Rheumatology Department, Hospital Universitario la Princesa, IIS-Princesa, Madrid, Spain, ⁷Hospital Universitario Marqués de Valdecilla, University of Cantabria Santander, Santander, Spain
Background/Purpose: Polymyalgia rheumatica (PMR) is often the presenting manifestation of giant cell arteritis (GCA). Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) scan often discloses the presence…
Abstract Number: 815 • 2018 ACR/ARHP Annual Meeting
Classic and Atypical Polymyalgia Rheumatica, Are Different Syndromes? Study of 93 Patients with PET/CT from a Single Center
Diana Prieto Peña¹, Monica Calderón Goercke¹, Javier Loricera², Isabel Martínez-Rodríguez³, Ignacio Banzo³, Belén Atienza-Mateo⁴, José Luis Martín-Varillas⁴, Vanesa Calvo-Río¹, Carmen Gonzalez Vela⁵, Miguel Angel González-Gay², José Luis Hernández² and Ricardo Blanco⁴, ¹Rheumatology, Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ²Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ³Nuclear Medicine, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ⁴Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ⁵Pathology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain
Background/Purpose: Polymyalgia rheumatica (PMR) is a common inflammatory rheumatic disease of the elderly whose diagnosis is usually based on clinical, analytical and ultrasound findings. However,…
Abstract Number: 1984 • 2015 ACR/ARHP Annual Meeting
Incidence and Intensity of 18fdg Uptake on Whole Body PET/CT in Patients with Polymyalgia Rheumatica
Claire Owen^1,2, Aurora Poon^3,4, Sze Ting Lee^2,3,4, Christine McMenamin¹, Kunthi Pathmaraj³, Andrew Scott^2,3,4 and Russell Buchanan^1,2, ¹Rheumatology, Austin Health, Heidelberg VIC, Australia, ²Medicine, University of Melbourne, Parkville VIC, Australia, ³Department of Molecular Imaging and Therapy, Austin Health, Heidelberg VIC, Australia, ⁴Olivia Newton-John Cancer Research Institute, Heidelberg VIC, Australia
Incidence and Intensity of 18FDG Uptake on Whole Body PET/CT in Patients with Polymyalgia Rheumatica C.E. Owen1,2, A.M.T. Poon2,3, S.T. Lee2,3,4, K. Pathmakaj3, C. McMenamin1,…
Abstract Number: 2771 • 2014 ACR/ARHP Annual Meeting
PET-CT Imaging and Association of Ferritin Autoantibodies in Polymyalgia Rheumatica
Niklas Thomas Baerlecken¹, Torsten Witte², Marco Amedeo Cimmino³ and Dario Camellino⁴, ¹Clinical Immunology and Rheumatology, MD, Hannover, Germany, ²Medical School Hannover, MD, Hanover, Germany, ³Clinica Reumatologica, Università di Genova, Genova, Italy, ⁴Dipartimento Medicina Interna, Clinica Reumatologica, Genova, Italy
Background/Purpose Previously we described antibodies against ferritin heavy chain peptide (anti-FHCP) in sera of patients with giant cell arteritis (GCA) and/or polymyalgia rheumatic (PMR) before…
Abstract Number: 2128 • 2014 ACR/ARHP Annual Meeting
Effectiveness of ¹⁸f-Fluoro-Dexoxyglucose Positron Emission Tomography for the Diagnosis of Polymyalgia-like Illness
Hideyuki Horikoshi¹, Takashi Nakanishi¹, Reiko Takahashi¹, Fumihiko Kimura² and Kenji Itoh¹, ¹Division of Rheumatology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan, ²National Defense Medical College, Tokorozawa, Japan
Background/Purpose: Polymyalgia rheumatica (PMR) is an inflammatory condition that affects the elderly. It is characterized by pain and stiffness in the shoulder and pelvic girdles. …

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].